• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维拉帕米胃漂浮型缓释胶囊的体外性能

In vitro performance of floating sustained-release capsule of verapamil.

作者信息

Chen G L, Hao W H

机构信息

Pharmaceutical Industry Technology and Development Center, Taipei, Taiwan, Republic of China.

出版信息

Drug Dev Ind Pharm. 1998 Nov;24(11):1067-72. doi: 10.3109/03639049809089950.

DOI:10.3109/03639049809089950
PMID:9876561
Abstract

Capsules filled with mixtures of verapamil, hydroxypropoxyl cellulose (HPC), and effervescent are proposed to provide floating sustained release over 10 hr. The effects of weight filled in the capsule, amount of HPC, and the addition of effervescent on the dissolution kinetics are studied. The conventional capsules were filled with different amounts and weights of the mixtures of verapamil, HPC, and effervescent. The release of verapamil from the capsules followed the Higuchi release model. However, when effervescent was added, a zero-order drug release was observed after the burst phase. The conventional capsule, when filled with active ingredients, polymers, and effervescent, can achieve a zero-order release system. Entrapped air was considered as a barrier to diffusion and matrix relaxation in drug release.

摘要

装有维拉帕米、羟丙基纤维素(HPC)和泡腾剂混合物的胶囊被提议用于提供超过10小时的漂浮缓释效果。研究了装入胶囊的重量、HPC的用量以及泡腾剂的添加对溶解动力学的影响。常规胶囊中装入了不同量和重量的维拉帕米、HPC和泡腾剂混合物。维拉帕米从胶囊中的释放遵循 Higuchi 释放模型。然而,当添加泡腾剂时,在爆发期后观察到零级药物释放。当常规胶囊填充有活性成分、聚合物和泡腾剂时,可以实现零级释放系统。截留的空气被认为是药物释放中扩散和基质松弛的障碍。

相似文献

1
In vitro performance of floating sustained-release capsule of verapamil.维拉帕米胃漂浮型缓释胶囊的体外性能
Drug Dev Ind Pharm. 1998 Nov;24(11):1067-72. doi: 10.3109/03639049809089950.
2
Factors affecting zero-order release kinetics of porous gelatin capsules.
Drug Dev Ind Pharm. 1998 Jun;24(6):557-62. doi: 10.3109/03639049809085658.
3
Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.盐酸尼卡地平缓释漂浮胶囊的制剂与评价
Pharmazie. 2003 Jan;58(1):38-43.
4
Formulation and development of gastroretentive drug delivery system for ofloxacin.氧氟沙星胃滞留型给药系统的制剂与研发。
Methods Find Exp Clin Pharmacol. 2006 Sep;28(7):433-9. doi: 10.1358/mf.2006.28.7.1003574.
5
Formulation of sustained-release verapamil HCl and diltiazem HCl semisolid matrix capsules.盐酸维拉帕米和盐酸地尔硫䓬缓释半固体基质胶囊的制剂
Pharm Dev Technol. 2008;13(2):115-25. doi: 10.1080/10837450701831070.
6
A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.对乙酰氨基酚熔融制粒的胶囊和片剂剂型溶出特性的比较研究——稀释剂的影响
Acta Pol Pharm. 2007 Jan-Feb;64(1):73-9.
7
Effect of varying drug loading on particle size distribution and drug release kinetics of verapamil hydrochloride microspheres prepared with cellulose esters.不同载药量对用纤维素酯制备的盐酸维拉帕米微球粒径分布和药物释放动力学的影响。
J Microencapsul. 1995 Jan-Feb;12(1):71-81. doi: 10.3109/02652049509051128.
8
Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.利用包含水溶性药物盐酸维拉帕米的pH非依赖性基质系统调节药物释放。
Pak J Pharm Sci. 2013 Jan;26(1):137-44.
9
In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.含纤维素聚合物混合物的亲水基质片剂中酮洛芬的体外释放。
Drug Dev Ind Pharm. 2013 Nov;39(11):1651-62. doi: 10.3109/03639045.2012.729146. Epub 2012 Oct 24.
10
Preparation of floating pellets with verapamil hydrochloride.盐酸维拉帕米胃漂浮微丸的制备
Acta Pol Pharm. 2004 May-Jun;61(3):185-90.

引用本文的文献

1
Cutting-Edge Developments and Patent Trends in Microspheres Drug Delivery: A Comprehensive Overview.微球药物递送的前沿发展与专利趋势:全面概述
Recent Pat Nanotechnol. 2025;19(3):434-452. doi: 10.2174/0118722105296316240626071243.
2
Formulation of a Gastroretentive In Situ Oral Gel Containing Metformin HCl Based on DoE.基于实验设计法的含盐酸二甲双胍胃滞留原位口服凝胶的制剂研发
Pharmaceutics. 2022 Aug 25;14(9):1777. doi: 10.3390/pharmaceutics14091777.
3
Development of a floating dosage form of ranitidine hydrochloride by statistical optimization technique.
采用统计优化技术研制盐酸雷尼替丁的漂浮剂型。
J Young Pharm. 2010 Oct;2(4):342-9. doi: 10.4103/0975-1483.71619.
4
In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet.盐酸肉桂嗪胃滞留片的体外释放动力学和生物利用度。
AAPS PharmSciTech. 2010 Mar;11(1):294-303. doi: 10.1208/s12249-010-9380-5. Epub 2010 Feb 25.
5
Floating drug delivery systems: a review.漂浮药物递送系统:综述
AAPS PharmSciTech. 2005 Oct 19;6(3):E372-90. doi: 10.1208/pt060347.